This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Alcon, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Innovations in Ophthalmic Visualization by Jonathan Che-Pin Chang
Introduction
Jonathan Che-Pin Chang is an accomplished inventor based in St. Louis, MO (US). He has made significant contributions to the field of ophthalmic visualization, particularly through his innovative patent. His work focuses on enhancing the visualization of ocular features, which is crucial for diagnosing and treating various eye conditions.
Latest Patents
Jonathan holds a patent titled "Methods and systems for enhanced ophthalmic visualization." This patent describes a system and computer-implemented method that utilizes a plurality of images corresponding to different portions of the electromagnetic spectrum. These images are combined, often through pixel-wise subtraction, to create a comprehensive image that enhances the visualization of important features, such as layers of the retina and pathological conditions. The combined image can be further processed using machine learning models to extract relevant features, thereby improving diagnostic capabilities.
Career Highlights
Jonathan is currently employed at Alcon, Inc., a leading company in the field of eye care. His work at Alcon has allowed him to apply his innovative ideas in a practical setting, contributing to advancements in ophthalmic technology. His dedication to improving patient outcomes through enhanced visualization techniques is commendable.
Collaborations
Jonathan has collaborated with notable colleagues, including Qing Xiang and John Park. These collaborations have likely fostered a creative environment that encourages the development of cutting-edge solutions in ophthalmic care.
Conclusion
In summary, Jonathan Che-Pin Chang is a notable inventor whose work in enhanced ophthalmic visualization has the potential to significantly impact the field of eye care. His innovative patent and contributions at Alcon, Inc. highlight his commitment to advancing medical technology for better patient outcomes.
